Skip to content

Keratized Mucosa in CG Implant Placement: CTG vs Flapless

Width of Keratinazed Mucosa in Immediately Loaded Posterior Implant Restorations Treated With Different Surgical Approaches: Randomized Clinical Study.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05073952
Enrollment
44
Registered
2021-10-12
Start date
2021-10-18
Completion date
2028-06-01
Last updated
2021-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Variation of Keratinized Mucosa After Implant Surgery

Keywords

dental implant, Keratinized mucosa, Connective tissue graft, flapless implant placement, Computer guided implantology, Immediate loading

Brief summary

The present study will evaluate the difference in terms of keratinazed mucosa (KM) in computer guided implant placement with immediate loading, comparing a flapless approach to flap surgery with connective tissue graft.

Interventions

PROCEDUREConnective tissue graft

Implants will be placed with a flap and a connective tissue graft.

PROCEDUREFlapless

Implants will be placed with a flapless approach

Sponsors

University of Milan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Masking description

surgical treatment will be conducted with surgeon-investigator and patient unblinded. the outcome assessor will be blinded as primary outcome measurements will be taken on a computer.

Intervention model description

two groups will be compared with different treatment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18+ * Patients with partial edentulism in the posterior region (4-7) upper or lower for at least 3 months * Patient whose tomographic examination shows adequate bone volumes for computer guided placement of a standard diameter implant (\> 3.5 mm) without the need for bone regeneration procedures * Patients who have accepted informed consent and participation in the study * Patients who do not have

Exclusion criteria

Eclusion Criteria * Patients who refuse to co-operate * Systemic conditions of exclusion: * Medical conditions requiring prolonged use of steroids * Severe hemophilia * In therapy with intravenous bisphosphonates * History of white blood cell dysfunction or deficiency * History of head and neck radiotherapy or chemotherapy * History of kidney failure * Pregnant or breastfeeding patient * History of uncontrolled endocrine disorders * Physical handicaps that hinder proper oral hygiene * Use of experimental devices or drugs within 30 days prior to implant placement surgery * Alcoholism or drug abuse * Smokers of\> 10 cigarettes per day or the equivalent cigar or\> 10 tobacco-based chewings per day * Conditions or circumstances that prevent the completion of participation in the study or interfere with the analysis of the study results Local exclusion conditions: * Local inflammation, including untreated periodontitis * Patients with erosive lichen planus * History of local radiation therapy * Presence of bone lesions * Unhealed extraction sites * History of bone reconstruction and bone grafting techniques in the sites where the implants are to be inserted * Bruxism * Bleeding index\> 30% and number of pockets\> 5mm greater than 10

Design outcomes

Primary

MeasureTime frameDescription
Widht of Keratinized mucosa2-4-8-12-24 weeks - 1-2-3-4-5 yearsvariation of keratized mucosa from t0

Secondary

MeasureTime frameDescription
marginal bone loss1-2-3-4-5 yearsvariation of marginal bone loss over time
Vas Scale2 weeksProm: patient VAS scale for post-operative pain, from 0 to 10, where 10 is higher and 0 is minimum.
implant survival1-2-3-4-5 yearsImplant in function

Other

MeasureTime frameDescription
Timeday 1surgical time differences between the two groups
prosthetic complications1-2-3-4-5 yearsnumber and type of prosthetic complications over time

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026